Jimenez, Adrian E.
Khalafallah, Adham M.
Botros, David
Horowitz, Melanie A.
Azmeh, Omar
Lam, Shravika
Oliveira, Leonardo A. P.
Chakravarti, Sachiv
Liu, Sophie
Wu, Esther
Wei, Oren
Porras, Jose L.
Bettegowda, Chetan
Tamargo, Rafael J.
Brem, Henry
Mukherjee, Debraj http://orcid.org/0000-0002-5403-8237
Article History
Received: 11 October 2021
Accepted: 27 November 2021
First Online: 2 December 2021
Declarations
:
: AJ declares that he has no conflict of interest. AM declares that he has no conflict of interest. DB declares that she has no conflict of interest. MH declares that she has no conflict of interest. OA declares that he has no conflict of interest. Shravika Lam declares that she has no conflict of interest. LO declares that he has no conflict of interest. SC declares that he has no conflict of interest. Sophie Liu declares that he has no conflict of interest. EW declares that she has no conflict of interest. OW declares that he has no conflict of interest. JP declares that he has no conflict of interest. CB is a consultant for Depuy-Synthes and Bionaut Labs. RT declares that he has no conflict of interest. HB is a consultant for AsclepiX Therapeutics, StemGen, InSightec, Accelerating Combination Therapies, NexImmune, Camden Partners, LikeMinds Inc., Galen Robotics Inc., and Nurami Medical, and he receives support from Arbor Pharmaceuticals, Bristol-Myers Squibb, and AcuityBio Corp. for non–study-related clinical or research effort. DB declares that he has no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: The Institutional Review Board (IRB), acting as a Health Insurance Portability and Accountability Act (HIPAA) Privacy Board, reviewed and approved the waiver of informed consent for this retrospective study (IRB00181593).